Skip to main content
Clinical Trials/JPRN-UMIN000050927
JPRN-UMIN000050927
Recruiting
未知

The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer:A prospective observational study - The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer

Department of Gastroenterology and Hepatology, Kurashiki Central Hospital0 sites120 target enrollmentApril 25, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
resectable pancreatic cancer
Sponsor
Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Enrollment
120
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2023
End Date
September 30, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Gastroenterology and Hepatology, Kurashiki Central Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with postoperative recurrence of pancreatic cancer 2\) Patients who are unable to undergo surgery after neoadjuvant chemotherapy 3\) Patients who are judged to be ineligible for this study by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials